marketcap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-13-2025
Aethlon Medical EPS Ratio 2011-2025 | AEMD
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio Aethlon Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -8.58 | -38.9 | -5.86 | -0.71 | -0.65 | -1.87 | -5.13 | -0.1 | -0.94 | -0.66 | -1.22 | -3.44 | -0.03 | -0.08 | -0.08 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -0.03 | -38.9 | -4.55 |
Quarterly EPS Ratio Aethlon Medical
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.85 | - | -0.13 | -0.2 | -2.76 | - | -1.37 | -1.22 | -1.35 | - | -1.24 | -1.84 | -0.19 | - | -0.16 | -0.46 | -0.29 | - | -0.2 | -0.2 | -0.15 | -0.15 | -0.28 | -0.28 | -1.29 | -0.11 | -1.67 | -0.11 | -0.08 | - | -0.08 | -0.14 | -0.21 | - | -0.15 | -0.72 | -0.57 | - | -0.16 | -0.5 | -0.34 | - | -0.26 | -1.12 | -0.92 | - | -0.01 | -0.03 | -0.02 | - | - | -0.01 | -0.02 | - | -0.01 | -0.04 | -0.03 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -0.01 | -2.76 | -0.498 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Dynatronics Corporation
DYNT
|
-1.43 | $ 0.24 | 14.99 % | $ 929 K |  USA |
 |
Aziyo Biologics
AZYO
|
-2.07 | $ 1.48 | 1.37 % | $ 20.5 M | USA |
 |
Natus Medical Incorporated
NTUS
|
0.39 | $ 31.08 | 1.94 % | $ 1.05 B | USA |
 |
Cardiovascular Systems
CSII
|
-0.94 | $ 20.0 | 0.15 % | $ 844 M | USA |
 |
Apollo Endosurgery
APEN
|
-0.98 | $ 10.0 | - | $ 475 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-1.64 | $ 16.3 | -0.46 % | $ 376 M | USA |
 |
Medtronic PLC
MDT
|
3.63 | $ 90.01 | -0.45 % | $ 116 B | USA |
 |
Viveve Medical
VIVE
|
-2.65 | $ 0.22 | -15.35 % | $ 1.71 M | USA |
 |
Myomo
MYO
|
-1.52 | $ 0.83 | -3.42 % | $ 5.85 M | USA |
 |
Invacare Corporation
IVC
|
-0.54 | $ 0.66 | - | $ 24.7 M | USA |
 |
Abiomed
ABMD
|
5 | $ 381.02 | - | $ 17.2 B | USA |
 |
Allied Healthcare Products
AHPI
|
-0.48 | $ 0.55 | 3.58 % | $ 2.21 M | USA |
 |
FONAR Corporation
FONR
|
1.78 | $ 14.9 | 1.02 % | $ 97.7 M | USA |
 |
ShockWave Medical
SWAV
|
4.01 | $ 334.75 | - | $ 12.3 B | USA |
 |
Quanterix Corporation
QTRX
|
-0.86 | $ 5.06 | -2.13 % | $ 190 M | USA |
 |
AVITA Medical
RCEL
|
-2.39 | $ 3.41 | -2.57 % | $ 88.3 M |  Australia |
 |
SeaSpine Holdings Corporation
SPNE
|
-1.62 | $ 7.16 | 0.28 % | $ 270 M | USA |
 |
ViewRay
VRAY
|
-0.59 | $ 2.64 | 1.54 % | $ 468 M | USA |
 |
Bruker Corporation
BRKR
|
0.76 | $ 39.0 | -2.99 % | $ 5.81 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-1.28 | $ 70.98 | - | $ 3.31 B | USA |
 |
Integer Holdings Corporation
ITGR
|
3.57 | $ 66.7 | -2.23 % | $ 2.24 B | USA |
 |
Sintx Technologies
SINT
|
-2.22 | $ 3.4 | -2.02 % | $ 12.7 M | USA |
 |
BIOLASE
BIOL
|
-29.4 | $ 0.13 | -13.19 % | $ 166 K | USA |
 |
Eargo
EAR
|
-39.7 | $ 2.57 | - | $ 10.2 M | USA |
 |
Delcath Systems
DCTH
|
-0.93 | $ 8.51 | -1.96 % | $ 243 M | USA |
 |
SmileDirectClub
SDC
|
-0.71 | $ 0.08 | -53.45 % | $ 9.71 M | USA |
 |
Globus Medical
GMED
|
0.76 | $ 61.25 | -0.44 % | $ 8.31 B | USA |
 |
ThermoGenesis Holdings
THMO
|
-20.4 | $ 0.31 | -25.84 % | $ 171 K | USA |
 |
Acutus Medical
AFIB
|
-2.81 | $ 0.09 | -26.83 % | $ 2.62 M | USA |
 |
ClearPoint Neuro
CLPT
|
-0.7 | $ 18.34 | 8.01 % | $ 496 M | USA |
 |
Surgalign Holdings
SRGA
|
-8.33 | $ 0.18 | -32.98 % | $ 1.68 M | USA |
 |
Conformis
CFMS
|
-6.99 | $ 2.27 | - | $ 16.4 M | USA |
 |
Sientra
SIEN
|
-1.1 | $ 0.18 | -16.59 % | $ 10.3 M | USA |
 |
NuVasive
NUVA
|
0.78 | $ 39.75 | - | $ 2.07 B | USA |
 |
Cutera
CUTR
|
-2.87 | $ 0.1 | -10.19 % | $ 1.99 M | USA |
 |
Nemaura Medical
NMRD
|
-0.57 | $ 0.11 | -17.8 % | $ 2.74 M |  Britain |
 |
Vapotherm
VAPO
|
-9.64 | $ 1.27 | 6.72 % | $ 34 M | USA |
 |
Pulmonx Corporation
LUNG
|
-1.44 | $ 1.75 | 2.65 % | $ 68.4 M | USA |